The XIAP-targeting antisense oligonucleotide AEG35156, when taken up by glial cells or neurons, leads to a reduction in XIAP levels within these cells, which can result in peripheral chemotherapy-induced neuropathy in patients.793. This evidence concerns the gene XIAP and neuropathy.